Listed

KALA BIO, Inc.

KALANasdaqCIK 1479419HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$1.7m, Q2 FY2026
Net income−$1.6m, Q2 FY2026
KALA BIO, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m5.6Research and development, Q3 FY2023, three months to 2023-09-30$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figurenot reported6.4Research and development, Q1 FY2024, three months to 2024-03-31$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure5.3Research and development, Q2 FY2024, three months to 2024-06-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure5.2Research and development, Q3 FY2024, three months to 2024-09-30$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reported6.1Research and development, Q1 FY2025, three months to 2025-03-31$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure6.2Research and development, Q2 FY2025, three months to 2025-06-30$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure6.1Research and development, Q3 FY2025, three months to 2025-09-30$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reported0.1Research and development, Q1 FY2026, three months to 2026-03-31$61.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure0.1Research and development, Q2 FY2026, three months to 2026-06-30$59.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Selling, general and administrative$m5.0Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$5.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure4.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$4.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2024-03-29, accession 0001558370-24-004326. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(8.8)Operating income, Q3 FY2023, three months to 2023-09-30−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure(9.6)Operating income, Q4 FY2023, three months to 2023-12-31−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004081. Derived: 12-month figure less the 9-month figure.Report this figure(11.9)Operating income, Q1 FY2024, three months to 2024-03-31−$11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure(9.6)Operating income, Q2 FY2024, three months to 2024-06-30−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure(10.0)Operating income, Q3 FY2024, three months to 2024-09-30−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure(9.5)Operating income, Q4 FY2024, three months to 2024-12-31−$9.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Operating income, Q1 FY2025, three months to 2025-03-31−$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(11.0)Operating income, Q2 FY2025, three months to 2025-06-30−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure(7.2)Operating income, Q3 FY2025, three months to 2025-09-30−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure(10.2)Operating income, Q4 FY2025, three months to 2025-12-31−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figure(1.8)Operating income, Q1 FY2026, three months to 2026-03-31−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(1.7)Operating income, Q2 FY2026, three months to 2026-06-30−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Interest expense$m1.5Interest expense, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure1.5Interest expense, Q4 FY2023, three months to 2023-12-31$1.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-29, accession 0001558370-24-004326. Derived: 12-month figure less the 9-month figure.Report this figure1.5Interest expense, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure1.5Interest expense, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure1.5Interest expense, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure1.4Interest expense, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figure1.1Interest expense, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure1.1Interest expense, Q2 FY2025, three months to 2025-06-30$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure1.0Interest expense, Q3 FY2025, three months to 2025-09-30$963.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure0.1Interest expense, Q4 FY2025, three months to 2025-12-31$141.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(8.7)Net income, Q3 FY2023, three months to 2023-09-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure(8.6)Net income, Q4 FY2023, three months to 2023-12-31−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004081. Derived: 12-month figure less the 9-month figure.Report this figure(11.8)Net income, Q1 FY2024, three months to 2024-03-31−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure(9.6)Net income, Q2 FY2024, three months to 2024-06-30−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure(9.0)Net income, Q3 FY2024, three months to 2024-09-30−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure(8.2)Net income, Q4 FY2024, three months to 2024-12-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figure(8.9)Net income, Q1 FY2025, three months to 2025-03-31−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(11.2)Net income, Q2 FY2025, three months to 2025-06-30−$11.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure(7.6)Net income, Q3 FY2025, three months to 2025-09-30−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure0.7Net income, Q4 FY2025, three months to 2025-12-31$686.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figure(1.6)Net income, Q1 FY2026, three months to 2026-03-31−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(1.6)Net income, Q2 FY2026, three months to 2026-06-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Diluted EPS$ per share(3.41)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$3.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figurenot reported(4.20)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$4.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure(3.16)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$3.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure(1.93)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reported(70.49)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$70.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(85.64)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$85.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure(1.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reported(0.14)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(21.32)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$21.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Basic EPS$ per share(3.41)Basic EPS, Q3 FY2023, three months to 2023-09-30−$3.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figurenot reported(4.20)Basic EPS, Q1 FY2024, three months to 2024-03-31−$4.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure(3.16)Basic EPS, Q2 FY2024, three months to 2024-06-30−$3.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure(1.93)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reported(70.49)Basic EPS, Q1 FY2025, three months to 2025-03-31−$70.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(85.64)Basic EPS, Q2 FY2025, three months to 2025-06-30−$85.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure(1.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reported(0.14)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(21.32)Basic EPS, Q2 FY2026, three months to 2026-06-30−$21.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure

Balance sheet

Cash and equivalents$229.0k, Q2 FY2026
Long-term debt$26.9m, Q3 FY2025
Shareholders' equity$9.0m, Q2 FY2026
KALA BIO, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m56.1Cash and equivalents, Q3 FY2023, at 2023-09-30$56.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure50.9Cash and equivalents, FY2023, at 2023-12-31$50.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001558370-25-004081.Report this figure48.5Cash and equivalents, Q1 FY2024, at 2024-03-31$48.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure54.2Cash and equivalents, Q2 FY2024, at 2024-06-30$54.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure49.2Cash and equivalents, Q3 FY2024, at 2024-09-30$49.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure51.2Cash and equivalents, FY2024, at 2024-12-31$51.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure42.2Cash and equivalents, Q1 FY2025, at 2025-03-31$42.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure31.9Cash and equivalents, Q2 FY2025, at 2025-06-30$31.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure21.1Cash and equivalents, Q3 FY2025, at 2025-09-30$21.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure7.6Cash and equivalents, FY2025, at 2025-12-31$7.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure1.8Cash and equivalents, Q1 FY2026, at 2026-03-31$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure0.2Cash and equivalents, Q2 FY2026, at 2026-06-30$229.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Current assets$m57.9Current assets, Q3 FY2023, at 2023-09-30$57.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure52.9Current assets, FY2023, at 2023-12-31$52.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004081.Report this figure50.1Current assets, Q1 FY2024, at 2024-03-31$50.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure58.9Current assets, Q2 FY2024, at 2024-06-30$58.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure51.3Current assets, Q3 FY2024, at 2024-09-30$51.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure52.8Current assets, FY2024, at 2024-12-31$52.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure45.7Current assets, Q1 FY2025, at 2025-03-31$45.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure33.7Current assets, Q2 FY2025, at 2025-06-30$33.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure24.3Current assets, Q3 FY2025, at 2025-09-30$24.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure9.5Current assets, FY2025, at 2025-12-31$9.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure12.3Current assets, Q1 FY2026, at 2026-03-31$12.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure10.6Current assets, Q2 FY2026, at 2026-06-30$10.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Total assets$m61.1Total assets, Q3 FY2023, at 2023-09-30$61.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure55.9Total assets, FY2023, at 2023-12-31$55.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001558370-25-004081.Report this figure53.0Total assets, Q1 FY2024, at 2024-03-31$53.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure61.6Total assets, Q2 FY2024, at 2024-06-30$61.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure54.1Total assets, Q3 FY2024, at 2024-09-30$54.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure55.5Total assets, FY2024, at 2024-12-31$55.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure48.3Total assets, Q1 FY2025, at 2025-03-31$48.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure36.1Total assets, Q2 FY2025, at 2025-06-30$36.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure25.0Total assets, Q3 FY2025, at 2025-09-30$25.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure9.5Total assets, FY2025, at 2025-12-31$9.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure12.3Total assets, Q1 FY2026, at 2026-03-31$12.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure10.6Total assets, Q2 FY2026, at 2026-06-30$10.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Current liabilities$m10.3Current liabilities, Q3 FY2023, at 2023-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure8.3Current liabilities, FY2023, at 2023-12-31$8.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004081.Report this figure11.9Current liabilities, Q1 FY2024, at 2024-03-31$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure19.2Current liabilities, Q2 FY2024, at 2024-06-30$19.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure23.9Current liabilities, Q3 FY2024, at 2024-09-30$23.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure17.0Current liabilities, FY2024, at 2024-12-31$17.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure23.0Current liabilities, Q1 FY2025, at 2025-03-31$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure16.0Current liabilities, Q2 FY2025, at 2025-06-30$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure32.6Current liabilities, Q3 FY2025, at 2025-09-30$32.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure2.5Current liabilities, FY2025, at 2025-12-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure1.6Current liabilities, Q1 FY2026, at 2026-03-31$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure1.5Current liabilities, Q2 FY2026, at 2026-06-30$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Total liabilities$m49.9Total liabilities, Q3 FY2023, at 2023-09-30$49.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure48.4Total liabilities, FY2023, at 2023-12-31$48.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001558370-25-004081.Report this figure46.4Total liabilities, Q1 FY2024, at 2024-03-31$46.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure47.9Total liabilities, Q2 FY2024, at 2024-06-30$47.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure47.2Total liabilities, Q3 FY2024, at 2024-09-30$47.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure43.2Total liabilities, FY2024, at 2024-12-31$43.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure42.5Total liabilities, Q1 FY2025, at 2025-03-31$42.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure39.3Total liabilities, Q2 FY2025, at 2025-06-30$39.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure33.7Total liabilities, Q3 FY2025, at 2025-09-30$33.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure2.5Total liabilities, FY2025, at 2025-12-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure1.6Total liabilities, Q1 FY2026, at 2026-03-31$1.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure1.5Total liabilities, Q2 FY2026, at 2026-06-30$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure
Long-term debt$m33.9Long-term debt, Q3 FY2023, at 2023-09-30$33.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure34.2Long-term debt, FY2023, at 2023-12-31$34.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-31, accession 0001558370-25-004081.Report this figure28.5Long-term debt, Q1 FY2024, at 2024-03-31$28.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure22.8Long-term debt, Q2 FY2024, at 2024-06-30$22.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure17.2Long-term debt, Q3 FY2024, at 2024-09-30$17.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure20.1Long-term debt, FY2024, at 2024-12-31$20.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure15.1Long-term debt, Q1 FY2025, at 2025-03-31$15.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure18.8Long-term debt, Q2 FY2025, at 2025-06-30$18.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure26.9Long-term debt, Q3 FY2025, at 2025-09-30$26.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reportednot reportednot reported
Current portion of debt$mnot reportednot reported6.0Current portion of debt, Q1 FY2024, at 2024-03-31$6.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure12.0Current portion of debt, Q2 FY2024, at 2024-06-30$12.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure18.0Current portion of debt, Q3 FY2024, at 2024-09-30$18.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure10.3Current portion of debt, FY2024, at 2024-12-31$10.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure15.5Current portion of debt, Q1 FY2025, at 2025-03-31$15.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure9.5Current portion of debt, Q2 FY2025, at 2025-06-30$9.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure28.4Current portion of debt, Q3 FY2025, at 2025-09-30$28.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figurenot reportednot reportednot reported
Shareholders' equity$m11.2Shareholders' equity, Q3 FY2023, at 2023-09-30$11.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure7.5Shareholders' equity, FY2023, at 2023-12-31$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-04-15, accession 0001104659-26-043782.Report this figure6.7Shareholders' equity, Q1 FY2024, at 2024-03-31$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure13.7Shareholders' equity, Q2 FY2024, at 2024-06-30$13.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure6.9Shareholders' equity, Q3 FY2024, at 2024-09-30$6.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure12.3Shareholders' equity, FY2024, at 2024-12-31$12.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure5.7Shareholders' equity, Q1 FY2025, at 2025-03-31$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure(3.2)Shareholders' equity, Q2 FY2025, at 2025-06-30−$3.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure(8.7)Shareholders' equity, Q3 FY2025, at 2025-09-30−$8.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure7.0Shareholders' equity, FY2025, at 2025-12-31$7.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure10.8Shareholders' equity, Q1 FY2026, at 2026-03-31$10.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure9.0Shareholders' equity, Q2 FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure

Cash flow

Operating cash flow−$1.5m, Q2 FY2026
KALA BIO, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(3.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001558370-24-015302. Derived: 9-month figure less the 6-month figure.Report this figure(7.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001558370-25-004081. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure(9.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001558370-25-010853. Derived: 6-month figure less the 3-month figure.Report this figure(4.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-19, accession 0001104659-25-113927. Derived: 9-month figure less the 6-month figure.Report this figure(4.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figure(8.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(16.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure(10.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-19, accession 0001104659-25-113927. Derived: 9-month figure less the 6-month figure.Report this figure(4.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-15, accession 0001104659-26-043782. Derived: 12-month figure less the 9-month figure.Report this figure(2.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure(1.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-19, accession 0001104659-26-098783. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)74,159, Q2 FY2026
KALA BIO, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,510,421 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001558370-23-018696.Report this figure2.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-312,069,186 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001558370-24-008134.Report this figure2.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-302,387,793 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001558370-24-011074.Report this figure2.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-302,550,210 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001558370-24-015302.Report this figure2.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-312,813,210 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001558370-25-007763.Report this figure3.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,030,213 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001558370-25-010853.Report this figure4.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-304,627,578 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure0.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31126,917 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure0.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30130,262 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure7.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-307,042,457 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-19, accession 0001104659-25-113927.Report this figure11.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3111,873,568 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-062397.Report this figure0.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3074,159 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure

Shares outstanding: 19.34mShares outstanding, period not labelled, at 2026-08-1419,339,786 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-19, accession 0001104659-26-098783.Report this figure at Aug 14, 2026, from the cover of the 10-Q filed Aug 19, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.